Want to see JP:4202 full AI Analyst Report?
4202 Stock Chart & Stats
¥1247.50
¥0.00(0.00%)
At close: 4:00 PM EST
¥1247.50
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥1,112.50 - ¥1,658.00
Previous CloseN/A
Volume682.20K
Average Volume (3M)536.76K
Market Cap
¥354.96B
Enterprise Value¥576.26B
Total Cash (Recent Filing)¥68.81B
Total Debt (Recent Filing)¥304.25B
Price to Earnings (P/E)35.9
Beta1.03
Next Earnings
Jul 30, 2026EPS Estimate
22.29Next Dividend Ex-DateN/A
Dividend Yield4.27%
Share Statistics
EPS (TTM)38.74
Shares Outstanding256,142,670
10 Day Avg. Volume480,400
30 Day Avg. Volume536,760
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)0.91
Price to Sales (P/S)0.56
P/FCF Ratio128.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,500.00Price Target Upside20.24% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)124.66
Revenue Forecast (FY)¥604.70B
Bulls Say, Bears Say
Bulls Say
Diversified B2B PortfolioDaicel supplies safety-system components, engineering plastics and specialty chemicals across automotive, electronics and industrial end markets. This diversified B2B mix and long-term supplier relationships reduce single-market exposure and support resilient demand and contractual revenues over months.
Steady Multi-year Revenue GrowthConsistent top-line growth provides a durable operating base that supports scale economics, investment in specialty grades, and customer retention. Even with recent margin pressure, steady revenue underpins recovery potential and makes operational improvements more impactful over the next quarters.
Improving Leverage MetricsReported reduction in leverage and stronger equity cushions improve financial resilience. Lower leverage reduces refinancing pressure and interest burden risk, giving the company more capacity to fund targeted capex or working-capital needs and withstand cyclical volatility over several months.
Bears Say
Profitability DeteriorationA sharp decline in net income and compressed operating margins indicate structural profit pressure from costs or mix shifts. Weakened profitability reduces retained earnings, limits reinvestment ability, and makes earnings more sensitive to raw-material or volume shocks across the medium term.
Volatile Free Cash FlowIrregular FCF generation constrains the company’s ability to consistently self-fund capex, pay down debt or maintain dividends. This variability increases reliance on external financing and reduces flexibility to pursue strategic initiatives during weaker quarters.
Sizable Absolute Debt BurdenEven with an improved debt-to-equity ratio, large absolute debt levels expose Daicel to interest-rate and refinancing risk. Significant borrowing can amplify earnings volatility in downturns and constrain strategic moves, limiting long-term financial flexibility.
Daicel News
4202 FAQ
What was Daicel’s price range in the past 12 months?
Daicel lowest stock price was ¥1112.50 and its highest was ¥1658.00 in the past 12 months.
What is Daicel’s market cap?
Daicel’s market cap is ¥354.96B.
When is Daicel’s upcoming earnings report date?
Daicel’s upcoming earnings report date is Jul 30, 2026 which is in 28 days.
How were Daicel’s earnings last quarter?
Daicel released its earnings results on May 12, 2026. The company reported -¥96.24 earnings per share for the quarter, missing the consensus estimate of ¥51.879 by -¥148.119.
Is Daicel overvalued?
According to Wall Street analysts Daicel’s price is currently Undervalued.
Does Daicel pay dividends?
Daicel pays a Semiannually dividend of ¥35 which represents an annual dividend yield of 4.27%. See more information on Daicel dividends here
What is Daicel’s EPS estimate?
Daicel’s EPS estimate is 22.29.
How many shares outstanding does Daicel have?
Daicel has 256,142,670 shares outstanding.
What happened to Daicel’s price movement after its last earnings report?
Daicel reported an EPS of -¥96.24 in its last earnings report, missing expectations of ¥51.879. Following the earnings report the stock price went down -7.58%.
Which hedge fund is a major shareholder of Daicel?
Currently, no hedge funds are holding shares in JP:4202
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Daicel
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
4202 Stock 12 Month Forecast
Average Price Target
¥1,500.00
▲(20.24% Upside)
Technical Analysis
Kaneka
―
Mitsubishi Gas Chemical Company
―
UBE Industries
―
Zeon
―
Sumitomo Bakelite Co., Ltd.
―
Options Prices
Currently, No data available
---










